Dana Investment Advisors, Inc. Neogenomics Inc Transaction History
Dana Investment Advisors, Inc.
- $2.96 Billion
- Q2 2025
A detailed history of Dana Investment Advisors, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 23,600 shares of NEO stock, worth $249,924. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,600
Previous 23,600
-0.0%
Holding current value
$249,924
Previous $223,000
22.87%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
309Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$208 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$150 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$78.7 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$72.5 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$54.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.33B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...